PAPER Zondagh LS, Malan SF, Joubert J
SEARCH RESULTS
5510 RESULTS
PAPER Sehlin D, Stocki P, Gustavsson T, Hultqvist G, Walsh FS, Rutkowski JL, Syvänen S
Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
FASEB J. 2020 Oct;34(10):13272-13283. Epub 2020 Aug 11 PubMed: 32779267PAPER Chen M, Li L, Liu C, Song L
Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer's disease.
Mol Cell Biochem. 2020 Nov;474(1-2):285-294. Epub 2020 Aug 10 PubMed: 32779043PAPER Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW, Saltiel N, Goldstein LE, Katz DI, Dwyer B, Daneshvar DH, Palmisano JN, Martin B, Cantu RC, Stern RA, Alvarez VE, Mez J, Stein TD, McKee AC
Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme.
Acta Neuropathol. 2020 Oct;140(4):495-512. Epub 2020 Aug 11 PubMed: 32778942PAPER Flagmeier P, De S, Michaels TC, Yang X, Dear AJ, Emanuelsson C, Vendruscolo M, Linse S, Klenerman D, Knowles TP, Dobson CM
Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation.
Nat Struct Mol Biol. 2020 Oct;27(10):886-891. Epub 2020 Aug 10 PubMed: 32778821PAPER Park L, Hochrainer K, Hattori Y, Ahn SJ, Anfray A, Wang G, Uekawa K, Seo J, Palfini V, Blanco I, Acosta D, Eliezer D, Zhou P, Anrather J, Iadecola C
Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration.
Nat Neurosci. 2020 Sep;23(9):1079-1089. Epub 2020 Aug 10 PubMed: 32778793PAPER Busche MA, Hyman BT
Synergy between amyloid-β and tau in Alzheimer's disease.
Nat Neurosci. 2020 Oct;23(10):1183-1193. Epub 2020 Aug 10 PubMed: 32778792PAPER Frost GR, Longo V, Li T, Jonas LA, Judenhofer M, Cherry S, Koutcher J, Lekaye C, Zanzonico P, Li YM
Author Correction: Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model.
Sci Rep. 2020 Aug 11;10(1):13826. PubMed: 32778663PAPER Swaminathan SK, Zhou AL, Ahlschwede KM, Curran GL, Lowe VJ, Li L, Kandimalla KK
High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma.
J Pharmacol Exp Ther. 2020 Nov;375(2):308-316. Epub 2020 Aug 10 PubMed: 32778535PAPER Farmer KM, Ghag G, Puangmalai N, Montalbano M, Bhatt N, Kayed R
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.
Acta Neuropathol Commun. 2020 Aug 10;8(1):132. PubMed: 32778161PAPER Woollacott IO, Toomey CE, Strand C, Courtney R, Benson BC, Rohrer JD, Lashley T
Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
J Neuroinflammation. 2020 Aug 10;17(1):234. PubMed: 32778130PAPER Sandoz M, Iglesias K, Achim AM, Démonet JF, Fossard M
Referential adjustment during discourse production in Alzheimer's disease.
J Clin Exp Neuropsychol. 2020 Sep;42(7):710-724. Epub 2020 Aug 11 PubMed: 32777976PAPER Kwon HS, Yang HR, Yun K, Baek JS, Kim YU, Park S, Choi H
The Effect of Cognitive Training in a Day Care Center in Patients with Early Alzheimer's Disease Dementia: A Retrospective Study.
Psychiatry Investig. 2020 Aug;17(8):829-834. Epub 2020 Aug 12 PubMed: 32777919PAPER Fathy YY, Hepp DH, de Jong FJ, Geurts JJ, Foncke EM, Berendse HW, van de Berg WD, Schoonheim MM
Anterior insular network disconnection and cognitive impairment in Parkinson's disease.
Neuroimage Clin. 2020;28:102364. Epub 2020 Jul 25 PubMed: 32781423PAPER Benge JF, Kiselica AM
Rapid communication: Preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson's disease.
Clin Neuropsychol. 2021 Jan;35(1):133-147. Epub 2020 Aug 11 PubMed: 32779959Current Filters
- Date Range : May 2020 to Aug 2020 x